{"id":"5d107c78-a2e8-409e-9b53-5aa8d34c431a","kind":"companies","code":"UB-C7813","name":"cytoReason","nameBasis":"source-english","summary":"cytoReason is a company headquartered in Tel Aviv, Israel.","description":"","country":"Israel","category":null,"originalName":"cytoReason","eventDate":null,"website":"https://www.cytoreason.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-15T17:10:20.070Z","reviewedAt":"2026-10-15T17:10:20.070Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"eff8fb2fa40ba87cfed1f3dc7fe1c528fef214bea982926ad6303b90790f8b89","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"d537c012-b7aa-4228-969b-b31e8ef7c43d","kind":"news","code":"d537c012-b7aa-4228-969b-b31e8ef7c43d","name":"cytoReason raises USD 80 million in strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"cytoReason完成8000万美元战略投资融资","eventDate":"2024-07-18T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:13.219Z","englishUpdatedAt":"2026-10-15T17:20:00.058Z","reviewedAt":"2026-10-15T17:20:00.058Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5eab5a1aa9aa0ec81ef053a5c3c43a64a2261db7adec1d7b0f6ccb91c732b2ac","companyId":"5d107c78-a2e8-409e-9b53-5aa8d34c431a","foundedYear":null,"logoUrl":null,"path":"/news/d537c012-b7aa-4228-969b-b31e8ef7c43d"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"218fad8b-352a-457a-b0bc-2c4a2caa9e6b","kind":"institutions","code":"UB-I6427","name":"OurCrowd","nameBasis":"original-brand","summary":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","description":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","country":null,"category":null,"originalName":"OurCrowd","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.628Z","englishUpdatedAt":"2026-10-15T18:26:24.748Z","reviewedAt":"2026-10-15T18:26:24.748Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"759ca3e00a6ca688e4c7f68dbc82d2408218948540768a729c4ccd2f91743657","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ourcrowd"},{"id":"c1b63651-6424-4490-8b22-296da7acc1c4","kind":"institutions","code":"UB-I5493","name":"赛默飞","nameBasis":"transliterated","summary":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","description":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","country":null,"category":null,"originalName":"赛默飞","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.525Z","englishUpdatedAt":"2026-10-15T18:26:25.115Z","reviewedAt":"2026-10-15T18:26:25.115Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f3dad43b23fb17595981da5749569b34d42b855b9ab40a1ad7864e75edeefd30","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Saimofei","path":"/institutions/saimofei"},{"id":"69d3b330-4676-467d-846b-bc919fe3fb57","kind":"institutions","code":"UB-I5386","name":"辉瑞制药","nameBasis":"transliterated","summary":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","description":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","country":null,"category":null,"originalName":"辉瑞制药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:29.534Z","englishUpdatedAt":"2026-10-15T18:43:03.653Z","reviewedAt":"2026-10-15T18:43:03.653Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"19d44125e90f4bdb356673c54854b5a6682643e7c06a0dc6965d465857d2bb5e","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Huiruizhiyao","path":"/institutions/huiruizhiyao"}],"finance":{"funding":{"metric":"funding","count":1,"latest":{"value":80000000,"text":"8000万美元","date":"2024-07-18T00:00:00.000Z","round":"Strategic","estimate":"$80M"},"years":[2024],"points":[{"year":2024,"date":"2024-07-18T00:00:00.000Z","round":"Strategic","value":80000000,"eventIds":["d537c012-b7aa-4228-969b-b31e8ef7c43d"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"d537c012-b7aa-4228-969b-b31e8ef7c43d","date":"2024-07-18T00:00:00.000Z","round":"Strategic","amountText":"8000万美元","estimateUsd":80000000,"estimateLabel":"$80M","estimateNote":null,"investors":"辉瑞制药,赛默飞,OurCrowd,Nvidia","institutions":[{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"218fad8b-352a-457a-b0bc-2c4a2caa9e6b","kind":"institutions","code":"UB-I6427","name":"OurCrowd","nameBasis":"original-brand","summary":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","description":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","country":null,"category":null,"originalName":"OurCrowd","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.628Z","englishUpdatedAt":"2026-10-15T18:26:24.748Z","reviewedAt":"2026-10-15T18:26:24.748Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"759ca3e00a6ca688e4c7f68dbc82d2408218948540768a729c4ccd2f91743657","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ourcrowd"},{"id":"c1b63651-6424-4490-8b22-296da7acc1c4","kind":"institutions","code":"UB-I5493","name":"赛默飞","nameBasis":"transliterated","summary":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","description":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","country":null,"category":null,"originalName":"赛默飞","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.525Z","englishUpdatedAt":"2026-10-15T18:26:25.115Z","reviewedAt":"2026-10-15T18:26:25.115Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f3dad43b23fb17595981da5749569b34d42b855b9ab40a1ad7864e75edeefd30","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Saimofei","path":"/institutions/saimofei"},{"id":"69d3b330-4676-467d-846b-bc919fe3fb57","kind":"institutions","code":"UB-I5386","name":"辉瑞制药","nameBasis":"transliterated","summary":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","description":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","country":null,"category":null,"originalName":"辉瑞制药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:29.534Z","englishUpdatedAt":"2026-10-15T18:43:03.653Z","reviewedAt":"2026-10-15T18:43:03.653Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"19d44125e90f4bdb356673c54854b5a6682643e7c06a0dc6965d465857d2bb5e","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Huiruizhiyao","path":"/institutions/huiruizhiyao"}],"newsUrl":null,"evidence":{"headline":"cytoReason raises USD 80 million in strategic financing","brief":null,"basis":null,"newsPath":"/news/d537c012-b7aa-4228-969b-b31e8ef7c43d","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"d537c012-b7aa-4228-969b-b31e8ef7c43d","date":"2024-07-18T00:00:00.000Z","round":"Strategic","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"辉瑞制药,赛默飞,OurCrowd,Nvidia","institutions":[{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"218fad8b-352a-457a-b0bc-2c4a2caa9e6b","kind":"institutions","code":"UB-I6427","name":"OurCrowd","nameBasis":"original-brand","summary":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","description":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","country":null,"category":null,"originalName":"OurCrowd","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.628Z","englishUpdatedAt":"2026-10-15T18:26:24.748Z","reviewedAt":"2026-10-15T18:26:24.748Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"759ca3e00a6ca688e4c7f68dbc82d2408218948540768a729c4ccd2f91743657","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ourcrowd"},{"id":"c1b63651-6424-4490-8b22-296da7acc1c4","kind":"institutions","code":"UB-I5493","name":"赛默飞","nameBasis":"transliterated","summary":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","description":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","country":null,"category":null,"originalName":"赛默飞","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.525Z","englishUpdatedAt":"2026-10-15T18:26:25.115Z","reviewedAt":"2026-10-15T18:26:25.115Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f3dad43b23fb17595981da5749569b34d42b855b9ab40a1ad7864e75edeefd30","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Saimofei","path":"/institutions/saimofei"},{"id":"69d3b330-4676-467d-846b-bc919fe3fb57","kind":"institutions","code":"UB-I5386","name":"辉瑞制药","nameBasis":"transliterated","summary":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","description":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","country":null,"category":null,"originalName":"辉瑞制药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:29.534Z","englishUpdatedAt":"2026-10-15T18:43:03.653Z","reviewedAt":"2026-10-15T18:43:03.653Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"19d44125e90f4bdb356673c54854b5a6682643e7c06a0dc6965d465857d2bb5e","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Huiruizhiyao","path":"/institutions/huiruizhiyao"}],"newsUrl":null,"evidence":{"headline":"cytoReason raises USD 80 million in strategic financing","brief":null,"basis":null,"newsPath":"/news/d537c012-b7aa-4228-969b-b31e8ef7c43d","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"d537c012-b7aa-4228-969b-b31e8ef7c43d","kind":"funding","eventDate":"2024-07-18T00:00:00.000Z","revenueDate":null,"round":"战略投资","amountText":"8000万美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":80000000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"辉瑞制药,赛默飞,OurCrowd,Nvidia","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"218fad8b-352a-457a-b0bc-2c4a2caa9e6b","kind":"institutions","code":"UB-I6427","name":"OurCrowd","nameBasis":"original-brand","summary":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","description":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","country":null,"category":null,"originalName":"OurCrowd","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.628Z","englishUpdatedAt":"2026-10-15T18:26:24.748Z","reviewedAt":"2026-10-15T18:26:24.748Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"759ca3e00a6ca688e4c7f68dbc82d2408218948540768a729c4ccd2f91743657","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ourcrowd"},{"id":"c1b63651-6424-4490-8b22-296da7acc1c4","kind":"institutions","code":"UB-I5493","name":"赛默飞","nameBasis":"transliterated","summary":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","description":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","country":null,"category":null,"originalName":"赛默飞","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.525Z","englishUpdatedAt":"2026-10-15T18:26:25.115Z","reviewedAt":"2026-10-15T18:26:25.115Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f3dad43b23fb17595981da5749569b34d42b855b9ab40a1ad7864e75edeefd30","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Saimofei","path":"/institutions/saimofei"},{"id":"69d3b330-4676-467d-846b-bc919fe3fb57","kind":"institutions","code":"UB-I5386","name":"辉瑞制药","nameBasis":"transliterated","summary":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","description":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","country":null,"category":null,"originalName":"辉瑞制药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:29.534Z","englishUpdatedAt":"2026-10-15T18:43:03.653Z","reviewedAt":"2026-10-15T18:43:03.653Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"19d44125e90f4bdb356673c54854b5a6682643e7c06a0dc6965d465857d2bb5e","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Huiruizhiyao","path":"/institutions/huiruizhiyao"}],"roundName":"Strategic","amountLabel":"$80M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"218fad8b-352a-457a-b0bc-2c4a2caa9e6b","kind":"institutions","code":"UB-I6427","name":"OurCrowd","nameBasis":"original-brand","summary":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","description":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","country":null,"category":null,"originalName":"OurCrowd","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.628Z","englishUpdatedAt":"2026-10-15T18:26:24.748Z","reviewedAt":"2026-10-15T18:26:24.748Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"759ca3e00a6ca688e4c7f68dbc82d2408218948540768a729c4ccd2f91743657","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ourcrowd"},{"id":"c1b63651-6424-4490-8b22-296da7acc1c4","kind":"institutions","code":"UB-I5493","name":"赛默飞","nameBasis":"transliterated","summary":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","description":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","country":null,"category":null,"originalName":"赛默飞","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.525Z","englishUpdatedAt":"2026-10-15T18:26:25.115Z","reviewedAt":"2026-10-15T18:26:25.115Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f3dad43b23fb17595981da5749569b34d42b855b9ab40a1ad7864e75edeefd30","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Saimofei","path":"/institutions/saimofei"},{"id":"69d3b330-4676-467d-846b-bc919fe3fb57","kind":"institutions","code":"UB-I5386","name":"辉瑞制药","nameBasis":"transliterated","summary":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","description":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","country":null,"category":null,"originalName":"辉瑞制药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:29.534Z","englishUpdatedAt":"2026-10-15T18:43:03.653Z","reviewedAt":"2026-10-15T18:43:03.653Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"19d44125e90f4bdb356673c54854b5a6682643e7c06a0dc6965d465857d2bb5e","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Huiruizhiyao","path":"/institutions/huiruizhiyao"}],"path":"/companies/cytoreason","structured":{"city":"Tel Aviv","country":"Israel","location":null,"role":null,"category":null,"company":null},"definition":"cytoReason is a company headquartered in Tel Aviv, Israel.","summaryBasis":"generated","thin":false,"canonical":"https://uniquebase.ai/companies/cytoreason"}